What should I know first?
Aripiprazole, the active medicine in Abilify, illustrates partial agonism. Its receptor effects depend on the target and experimental system.
This lesson uses UK Abilify tablet pharmacology. It does not carry over American indications or imply that oral and long-acting injectable products have identical licences.
This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.
How Brain Cells Communicate
An agonist activates a receptor. A partial agonist can activate it but produces a smaller maximum response than a full agonist in a defined experimental system. This describes an assay result, not a fixed percentage of a person’s dopamineDopamineA chemical messenger involved in movement, learning and emotion. Its name does not describe one feeling or one role throughout the brain.Read the full definition of Dopamine activity.
- Dopamine
A messenger can change signaling through its receptor.
- D2 receptor
This receptor symbol identifies a function, not a molecular structure.
- Cell response
The arrow represents a signaling response, not movement through a pore.
Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.
About this illustration
A full agonist is a reference for a larger maximum response in the same experimental system. No universal numerical response is assumed.
How the Medication Changes Signalling
The Abilify label describes partial agonist activity at dopamine D2 and serotoninSerotoninA chemical messenger involved in several functions, including sleep, mood and digestion. It acts through different receptors, with effects that depend on the cell.Read the full definition of Serotonin 5-HT1A receptors, with antagonist activity at serotonin 5-HT2A receptors. One medicine can have different actions at different receptor types.
A partial agonist can also compete with a fuller agonist at a receptor. The net effect depends on the surrounding signalling and the response being measured. It is not an automatic brain-wide “normaliser.”
A Closer Look at the Molecular Level
Known action: receptor experiments support context-dependent partial agonism. Studies of cloned human dopamine receptors investigate functional responses in particular experimental systems.
The UK product information proposes a combination of partial agonism and antagonism as the basis of therapeutic effects. This does not amount to a universal numerical fraction of dopamine activity. A half-filled symbol would suggest false precision, so this lesson uses words instead.
Sources and References
- Abilify 30 mg tablets: UK SmPC
Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.
Scope: United Kingdom.
- What Is a Neurotransmitter?
Scope: International scientific education; not UK regulatory evidence.
- Shapiro and colleagues: aripiprazole in cloned receptor systems
Scope: International laboratory research.
Article Information
- Edition
- United Kingdom
- Content updated
- 2026-10-17
- Sources checked
- Listed with each reference above; retained dates for shared scientific content.
- Publication status
- Published
- Scope
- How this medicine works, with UK product information.
Source and coverage limits
- A mechanism lesson is not a complete medicine profile, dosing schedule or individual treatment recommendation.
- Original qualitative SVG diagrams explain direction and target type; they do not measure biological rates, binding geometry or clinical response.

